SCHEMBL6889437

SCHEMBL6889437

CC(N)CCCCCCCCCn1c(=O)c2c(ncn2C)n(C)c1=O

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA2B P29275 7/20 0.62
▸ TNF P01375 4/20 0.62
▸ USP2 O75604 1/20 0.62
▸ LMNA P02545 1/20 0.62
▸ CYP1A2 P05177 1/20 0.62
▸ TSHR P16473 1/20 0.62
▸ NFKB1 P19838 1/20 0.62
▸ ACHE P22303 1/20 0.62
▸ PDE4A P27815 1/20 0.62
▸ PMP22 Q01453 1/20 0.62
▸ PDE4B Q07343 1/20 0.62
▸ PDE4C Q08493 1/20 0.62
▸ PDE4D Q08499 1/20 0.62
▸ SMN1; SMN2 Q16637 1/20 0.62
▸ RXFP1 Q9HBX9 1/20 0.62
▸ CHIT1 Q13231 1/20 0.57
▸ CHIA Q9BZP6 1/20 0.57
▸ AKR1B1 P15121 1/20 0.55
▸ GLA P06280 1/20 0.54
▸ BLM P54132 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6884837 1.00 ADORA2B (0.62) ADORA2BTNFUSP2LMNACYP1A2
SCHEMBL6346622 0.99 ADORA2B (0.64) ADORA2BTNFUSP2LMNACYP1A2
SCHEMBL6346627 0.99 ADORA2B (0.64) ADORA2BTNFUSP2LMNACYP1A2
SCHEMBL15790447 0.88 ADORA2B (0.67) ADORA2BTNFUSP2LMNACYP1A2
SCHEMBL16120981 0.88 ADORA2B (0.77) ADORA2BTNFUSP2LMNACYP1A2
SCHEMBL6779520 0.88 ADORA2B (0.66) ADORA2BTNFUSP2LMNACYP1A2
SCHEMBL6777369 0.88 ADORA2B (0.66) ADORA2BTNFUSP2LMNACYP1A2
SCHEMBL6778207 0.88 ADORA2B (0.66) ADORA2BTNFUSP2LMNACYP1A2
SCHEMBL8686678 0.88 ADORA2B (0.66) ADORA2BTNFUSP2LMNACYP1A2
SCHEMBL6778919 0.88 ADORA2B (0.66) ADORA2BTNFUSP2LMNACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1460074-A1 Substituted amino alkyl compounds CELL THERAPEUTICS, INC. (US) 2004-09-22 — — EP disclosed
US-5889011-A THERAPY FOR SEPSIS; ORGAN TOXICITY, ALOPECIA, ANTIINFLAMMATORY AGENTS, AUTOIMMUNE DISEASES CELL THERAPEUTICS, INC. (US) 1999-03-30 — — US disclosed
US-5817662-A THERAPY FOR SEPTIC SHOCK, ALOPECIA; INFLAMMATION;AUTOIMMUNE DISEASES CELL THERAPEUTICS, INC. (US) 1998-10-06 — — US disclosed
EP-0623133-A4 SUBSTITUTED AMINO ALKYL COMPOUNDS. CELL THERAPEUTICS INC (US) 1995-10-11 — — EP disclosed
EP-0623133-A1 SUBSTITUTED AMINO ALKYL COMPOUNDS CELL THERAPEUTICS, INC. (US) 1994-11-09 — — EP disclosed
US-5340813-A Therapeutical agent can maintain cellular hemeostasis in the face of variety of inflammatory stimuli CELL THERAPEUTICS, INC. (US) 1994-08-23 — — US disclosed
WO-1994011370-A1 SUBSTITUTED AMINO ALKYL COMPOUNDS CELL THERAPEUTICS, INC. (US) 1994-05-26 — — WO disclosed
Send feedback